Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
265 hedge funds and large institutions have $997M invested in Avanos Medical in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 35 closing their positions.
358% more call options, than puts
Call options by funds: $541K | Put options by funds: $118K
17% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 35
13% more capital invested
Capital invested by funds: $884M → $997M (+$113M)
2.49% more ownership
Funds ownership: 93.14% → 95.63% (+2.5%)
2% more funds holding
Funds holding: 260 → 265 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 78
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$10.1M |
| 2 |
BlackRock
New York
|
+$6.77M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$4.72M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.66M |
| 5 |
RC
RGM Capital
Naples,
Florida
|
+$4.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$12.8M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$3.76M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$2.54M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$1.9M |
| 5 |
Two Sigma Investments
New York
|
-$1.26M |
AVNS Hedge Fund Activity: Q4 2023 in Review
265 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2023, worth a combined $997M — up 13% from $884M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new AVNS positions and 35 closed out — a net gain of 6 holders — while 67 added to existing stakes and 78 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $10.1M. The largest seller was Paradice Investment Management, cutting an estimated $12.8M.
- 265 institutional investors held Avanos Medical (AVNS) as of Q4 2023, up from 260 in Q3 2023.
- Funds reported $997M of Avanos Medical stock for Q4 2023, up 13% quarter-over-quarter.
- 41 funds opened new Avanos Medical positions in Q4 2023 and 35 closed out, a net change of +6 holders.
- The largest Avanos Medical buyer in Q4 2023 was Morgan Stanley, an estimated $10.1M added.
- The largest Avanos Medical seller in Q4 2023 was Paradice Investment Management, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2023.